DK129127B - Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(furylmethyl)-6,7-benzomorphaner eller deres syreadditionssalte. - Google Patents

Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(furylmethyl)-6,7-benzomorphaner eller deres syreadditionssalte.

Info

Publication number
DK129127B
DK129127B DK53372AA DK53372A DK129127B DK 129127 B DK129127 B DK 129127B DK 53372A A DK53372A A DK 53372AA DK 53372 A DK53372 A DK 53372A DK 129127 B DK129127 B DK 129127B
Authority
DK
Denmark
Prior art keywords
benzomorphans
furylmethyl
racemic
preparation
acid addition
Prior art date
Application number
DK53372AA
Other languages
Danish (da)
English (en)
Other versions
DK129127C (US08088918-20120103-C00476.png
Inventor
H Merz
A Langbein
H Wick
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2105743A external-priority patent/DE2105743C3/de
Priority claimed from DE19712108954 external-priority patent/DE2108954A1/de
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK129127B publication Critical patent/DK129127B/da
Application granted granted Critical
Publication of DK129127C publication Critical patent/DK129127C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
DK53372AA 1971-02-08 1972-02-07 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(furylmethyl)-6,7-benzomorphaner eller deres syreadditionssalte. DK129127B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2105743A DE2105743C3 (de) 1971-02-08 1971-02-08 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
DE19712108954 DE2108954A1 (en) 1971-02-25 1971-02-25 2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents

Publications (2)

Publication Number Publication Date
DK129127B true DK129127B (da) 1974-08-26
DK129127C DK129127C (US08088918-20120103-C00476.png) 1975-02-10

Family

ID=25760626

Family Applications (1)

Application Number Title Priority Date Filing Date
DK53372AA DK129127B (da) 1971-02-08 1972-02-07 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(furylmethyl)-6,7-benzomorphaner eller deres syreadditionssalte.

Country Status (25)

Country Link
US (1) US3823150A (US08088918-20120103-C00476.png)
JP (1) JPS5545555B1 (US08088918-20120103-C00476.png)
AT (3) AT318602B (US08088918-20120103-C00476.png)
BE (1) BE779058A (US08088918-20120103-C00476.png)
BG (3) BG19600A3 (US08088918-20120103-C00476.png)
CA (1) CA969938A (US08088918-20120103-C00476.png)
CH (4) CH573933A5 (US08088918-20120103-C00476.png)
CS (4) CS166801B2 (US08088918-20120103-C00476.png)
DD (1) DD95847A5 (US08088918-20120103-C00476.png)
DK (1) DK129127B (US08088918-20120103-C00476.png)
ES (4) ES399536A1 (US08088918-20120103-C00476.png)
FI (1) FI57758C (US08088918-20120103-C00476.png)
FR (1) FR2124564B1 (US08088918-20120103-C00476.png)
GB (1) GB1384115A (US08088918-20120103-C00476.png)
HU (1) HU162946B (US08088918-20120103-C00476.png)
IE (1) IE36071B1 (US08088918-20120103-C00476.png)
IL (1) IL38699A (US08088918-20120103-C00476.png)
NL (1) NL171898C (US08088918-20120103-C00476.png)
NO (1) NO134054C (US08088918-20120103-C00476.png)
PH (1) PH10743A (US08088918-20120103-C00476.png)
PL (2) PL78312B1 (US08088918-20120103-C00476.png)
RO (5) RO59193A (US08088918-20120103-C00476.png)
SE (1) SE363630B (US08088918-20120103-C00476.png)
SU (4) SU469246A3 (US08088918-20120103-C00476.png)
YU (3) YU35016B (US08088918-20120103-C00476.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
US4010164A (en) * 1973-03-28 1977-03-01 Boehringer Ingelheim Gmbh N-(furyl-methyl)-2-hydroxy-5,9,9-trimethyl-benzomorphans and salts thereof
SU510999A3 (ru) * 1973-10-27 1976-04-15 К.Х.Берингер Зон, (Фирма) Способ получени (метоксиметил-фурилметил)6,7-бензоморфанов илиморфинанов
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
DE2437610A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
DE3839659A1 (de) * 1988-11-24 1990-05-31 Boehringer Ingelheim Kg Verwendung von benzomorphanen zur zytoprotektion
AR069545A1 (es) * 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
EP2245014B1 (en) * 2008-02-12 2011-11-02 Boehringer Ingelheim International GmbH Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
TW200950780A (en) 2008-05-13 2009-12-16 Boehringer Ingelheim Int Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
WO2013025664A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1281227A (fr) * 1958-09-22 1962-01-12 Smith Kline French Lab Perfectionnements apportés aux procédés pour la préparation de dérivés d'aralcoylbenzomorphane
FR1538362A (fr) * 1966-05-20 1968-09-06 Merck & Co Inc Dérivés du benzomorphane

Also Published As

Publication number Publication date
CH574442A5 (US08088918-20120103-C00476.png) 1976-04-15
RO59165A (US08088918-20120103-C00476.png) 1976-02-15
CS166803B2 (US08088918-20120103-C00476.png) 1976-03-29
YU172078A (en) 1980-04-30
SE363630B (US08088918-20120103-C00476.png) 1974-01-28
NL171898B (nl) 1983-01-03
PL78312B1 (en) 1975-06-30
CS166802B2 (US08088918-20120103-C00476.png) 1976-03-29
CS166801B2 (US08088918-20120103-C00476.png) 1976-03-29
ES408276A1 (es) 1975-11-16
CH573934A5 (US08088918-20120103-C00476.png) 1976-03-31
ES408274A1 (es) 1976-02-01
YU35255B (en) 1980-10-31
NO134054B (US08088918-20120103-C00476.png) 1976-05-03
JPS5545555B1 (US08088918-20120103-C00476.png) 1980-11-18
IE36071B1 (en) 1976-08-04
DK129127C (US08088918-20120103-C00476.png) 1975-02-10
HU162946B (US08088918-20120103-C00476.png) 1973-05-28
RO63052A (fr) 1978-06-15
FR2124564B1 (US08088918-20120103-C00476.png) 1975-10-31
CH573935A5 (US08088918-20120103-C00476.png) 1976-03-31
IE36071L (en) 1973-06-08
CS166804B2 (US08088918-20120103-C00476.png) 1976-03-29
ES399536A1 (es) 1974-11-01
IL38699A (en) 1975-12-31
BG19800A3 (US08088918-20120103-C00476.png) 1975-10-10
ES408275A1 (es) 1976-02-16
PL84115B3 (en) 1976-03-31
SU469246A3 (ru) 1975-04-30
BE779058A (fr) 1972-08-07
SU421187A3 (ru) 1974-03-25
PH10743A (en) 1977-09-01
FI57758B (fi) 1980-06-30
BG20792A3 (US08088918-20120103-C00476.png) 1975-12-20
CH573933A5 (US08088918-20120103-C00476.png) 1976-03-31
CA969938A (en) 1975-06-24
YU27972A (en) 1979-12-31
SU479290A3 (ru) 1975-07-30
US3823150A (en) 1974-07-09
RO58981A (US08088918-20120103-C00476.png) 1975-11-15
RO59251A (US08088918-20120103-C00476.png) 1976-05-15
NL171898C (nl) 1983-06-01
FR2124564A1 (US08088918-20120103-C00476.png) 1972-09-22
AT318602B (de) 1974-11-11
GB1384115A (en) 1975-02-19
BG19600A3 (US08088918-20120103-C00476.png) 1975-06-25
AT318601B (de) 1974-11-11
YU35016B (en) 1980-06-30
NO134054C (US08088918-20120103-C00476.png) 1976-08-11
RO59193A (US08088918-20120103-C00476.png) 1976-01-15
FI57758C (fi) 1980-10-10
DD95847A5 (US08088918-20120103-C00476.png) 1973-02-20
AT312587B (de) 1974-01-10
NL7201551A (US08088918-20120103-C00476.png) 1972-08-10
SU467519A3 (ru) 1975-04-15
IL38699A0 (en) 1972-04-27

Similar Documents

Publication Publication Date Title
DK136904B (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive 2-(heteroarylmethyl)-5,9beta-dialkyl-6,7-benzomorphaner eller syreadditionssalte deraf
DK131029B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.
DK129447B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.
DK138602B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner eller salte deraf.
DK142750C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive dopaminderivater eller syreadditionssalte deraf
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK129127B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(furylmethyl)-6,7-benzomorphaner eller deres syreadditionssalte.
DK136713B (da) Analogifremgangsmåde til fremstilling af alfa-aryl-4-substituerede piperidinoalkanolderivater eller deres syreadditionssalte.
DK122133B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK121512B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 5-phenyl-6,7-benzomorphaner eller syreadditionssalte deraf.
DK126644B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive hydroxycrotonsyrer eller salte deraf med uorganiske eller organiske baser.
DK131778B (da) Fremgangsmåde til fremstilling af substituerede 3-hydroksymetylisokinolinderivater eller syreadditionssalte heraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK129235B (da) Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
DK131857B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf.
DK138943B (da) Analogifremgangsmåde til fremstilling af substituerede dibenzocyclohepten-carboxamider eller syreadditionssalte deraf.
DK130344B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater eller syreadditionssalte deraf.
DK136823B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive derivater af imidazo(2,1-b)thiazol eller syreadditionssalte deraf.
DK123102B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzo[b]thiopheneddikesyreforbindelser eller carboxylatsalte deraf.
DK129992B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 3,5-disubstituerede fenylætanolaminforbindelser eller terapeutisk acceptable syreadditionssalte deraf.
DK136069B (da) Fremgangsmåde til fremstilling af quinolinderivater, antipoder eller racemater eller syreadditionssalte deraf.
DK134014B (da) Analogifremgangsmåde til fremstilling af cycloalkyllactamimider eller syreadditionssalte deraf.
DK131470B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive thiazolino-pyrimidin-5-on derivater eller syreadditionssalte deraf.
DK129718B (da) Analogifremgangsmåde til fremstilling af tiazolino-pyrimidin-5-oner eller deres syreadditionssalte eller de tilsvarende optisk aktive forbindelser.

Legal Events

Date Code Title Description
PBP Patent lapsed